Doximity
DOCS on XNYS, Doximity, Inc.
Measures activity, not value. Not investment advice.
Latest quarter (Jul 2026)
+3.6%
-13.2 pts vs its 3-year median
Sharp changes
0
quarterly revenue change, quarterly capital spending jump
What usually follows Revenue growth was not followed by a clear share-price difference over the next 6 months. No relationship found How we measured it
10-Q and 10-K figures, by the quarter they describe. Dashed: 3-year median.
See the numbers
| Quarter of Jul 2026: +3.6% |
| Quarter of Apr 2026: +7.3% |
| Quarter of Jan 2026: +5.1% |
| Quarter of Oct 2025: +9.8% |
| Quarter of Jul 2025: +23% |
| Quarter of Apr 2025: +15% |
| Quarter of Jan 2025: +17% |
| Quarter of Oct 2024: +25% |
| Quarter of Jul 2024: +20% |
| Quarter of Apr 2024: +17% |
| Quarter of Jan 2024: +6.4% |
| Quarter of Oct 2023: +17% |
| Quarter of Jul 2023: +11% |
| Quarter of Apr 2023: +20% |
| Quarter of Jan 2023: +18% |
| Quarter of Oct 2022: +18% |
| Quarter of Jul 2022: +29% |
| Quarter of Apr 2022: +25% |
| Quarter of Jan 2022: +40% |
| Quarter of Oct 2021: +67% |
| Quarter of Jul 2021: +76% |
| Quarter of Apr 2021: +100% |
What the numbers say
- Median revenue growth on a year earlier: +3.6% in the quarter from 1 Jul 2026 (3-year median +17%).
- Median growth on a year earlier, latest complete quarter: the largest is R&D expense, +39%.
See the numbers
| R&D expense | +39% |
| Revenue | +3.6% |
| Deferred revenue | +0.2% |
Every measure from this source
5 years, by the period each figure describes
Sharp changes
0 in all loaded history, strongest first
No sharp change of this kind in all loaded history.
The records
One row per company, data through 1 Nov 2026
Showing 1 to 1 of 1.
| Company | Sector | Latest quarter | vs year before |
|---|---|---|---|
| Doximity | Technology | $174.5M |